Guaifenesin

Analytical Profiles of Drug Substances and Excipients

Volumn 25, Issue C, 1998, Pages 121-164

  SherVington, Leroy A ^a   Sherrington, Amal ^b  

^a JORDANIAN PHARMACEUTICAL MANUFACTURING COMPANY   (Jordan)

^b UNIVERSITY OF JORDAN   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0013407801     PISSN: 10756280     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0099-5428(08)60754-6     Document Type: Article

References (32)

1. A. H. F. S, 96, Drug Information American Hospital Formulary Service.
2. S. Alessi-Severini, F. Jamali, R. T. Coutts, and F. M. Pasutto, "Methocarbamol", chapter 9 in Analytical Profiles of Drug Substances and Excipients, H. G. Brittain, ed., Volume 23, pp. 371-398 (1994).
3. R. Mickova, M. Hruby, Z. Halicka, J. Trojanek, and M. Ferenc, Czech Rep., CZ, 278, 414 (CI. C07D236/24) (1994).
4. H. L. Yale, E. J. Pribyl, W. Braker, F. H. Bergeim, and W. A. Lott, J. Am. Chem. Soc, 72, 3710(1950).
5. Danuta Dabrowska, Pol. 42379(1959).
6. T. Kametani, T. Suzuki, K. Kigasawa, and M. Hiiragi, Yakugaku Zasshi, 87, 967(1967).
7. th Edition (1991).
8. L. A. Shervington, M. Al-Omari, and A. Abdoh, Anal. Lett., submitted for publication.
9. D. Jordan, J. Pharm. Sci., 82, 1269(1993).
10. H. Fischer and A. Newcombe, Can. J. Research, 26 B, 393(1948).
11. United States Pharmacopoeia 23, Third Supplement, 2936(1995).
12. M. E. Aulton, "Pharmaceutics", in The Science of Dosage Form Design, pp. (1994).
13. G. W. Schieffer, W. O. Smith, G. S. Lubey, and D. G. Newby, J. Pharm. Sci., 73, 1856(1984).
14. S. Singhawangcta, C. F. Poole, and A. Zlatkis, J. Chromatography, 183, 433(1984).
15. R. M. Gudipati, J. E. Wallace, and S. A. Stavchansky, Anal. Lett., 24, 265(1991).
16. J. B. Aluri and S. Stavchansky, J. Pharm. Biomed. Anal., 11, 803(1993).
17. S. Stavchansky, S. Demirbas, L. Reyderman, and C. Chai, J. Pharm. Biomed. Anal, 13, 919(1995).
18. H. C. Ketelaars and J. G. Peters, J. Chromatography, 224, 144(1981).
19. W. J. Vandenheuvel, J. L. Smith, and R. H. Silber, J. Pharm. Sci., 61, 1997(1972).
20. A. R. Lee and T. M. Hu, J. Pharm. Biomed. Anal, 12, 747(1994).
21. G. R. Rao, A. B. Auadhanulu, R. Giridhar, and C. K. Kokate, East Pharm., 31, 141(1988).
22. M. Bambagiotti-Alberti, S. Pinzauti, and F. F. Vincieri, Pharm. Act. Helv., 62, 175(1987).
23. F. Jensen, Medd-Nor-Farm-Selsk, 39, 38(1977).
24. M. Yururi, H. Nakanishi, and K. Taniguchi, Bunseki-Kagaku, 43, 575(1994).
25. D. K. Desai, S. P. Kurani, A. G. Seshadrinathan, Indian J. Pharm. Sci., 41, 210(1985).
26. H. Tomankova and M. Vasatova, Pharmazie, 44, 197(1989).
27. L. A. Shervington, Anal. Lett., 30(1997).
28. D. L. Wagner and V. S. Patel, Int. J. Pharm., 114, 171(1995).
29. H. R. Bhagat, R. W. Mendes, E. Mathiowitz, and H. N. Bhargava, Drug Dev. Ind. Pharm., 20, 387(1994).
30. G. Kauert, L. Meyer, and G., Drasch. Dtsch. Apoth. Ztg, 119, 986(1979).
31. J. Thomas, Aust. J. Pharm., 71, 101(1990).
32. D. B. Newgreen and V. Chladek, Aust. J. Pharm., 62, 303(1981).